This inventor holds 1 USPTO granted patent. Top assignee: Novartis Ag. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Helen Elizabeth Oakman: Innovator in Organic Compounds
Introduction
Helen Elizabeth Oakman is a notable inventor based in Horsham, GB. She has made significant contributions to the field of organic chemistry, particularly in the development of compounds that have potential therapeutic applications.
Latest Patents
Helen holds a patent for organic compounds, specifically pyrazolo[5.1-b]oxazole derivatives. These compounds are recognized for their utility as corticotropin releasing factor (CRF) receptor antagonists. This innovation showcases her expertise in creating compounds that may have important implications in medical science.
Career Highlights
Helen is currently associated with Novartis AG, a leading global healthcare company. Her work at Novartis has allowed her to focus on innovative research and development in the pharmaceutical sector.
Collaborations
Throughout her career, Helen has collaborated with esteemed colleagues, including François Gessier and James Neef. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Helen Elizabeth Oakman is a distinguished inventor whose work in organic compounds has the potential to impact the field of medicine significantly. Her contributions reflect her dedication to innovation and research in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile